Wound Healing and Patient-Reported Outcomes After Gingival Graft Harvesting From the Palate
1 other identifier
interventional
66
1 country
1
Brief Summary
The goal of this clinical trial is to evaluate whether two different techniques for treating palatal wounds-sutures and cyanoacrylate bioadhesive-can influence postoperative morbidity, clinical healing, and soft tissue dimensional changes in patients undergoing epithelialized gingival graft harvesting from the palate. The main questions it aims to answer are: Does the use of cyanoacrylate bioadhesive reduce postoperative morbidity compared to sutures? Does the choice of wound treatment technique affect clinical healing and three-dimensional changes in soft tissues? Researchers will compare the sutures (control group) to the cyanoacrylate bioadhesive (test group) to determine if the bioadhesive leads to improved postoperative outcomes. Participants will: Undergo epithelialized gingival graft harvesting from the palate. Receive either sutures or cyanoacrylate bioadhesive for wound closure. Be monitored for postoperative morbidity, clinical healing, and soft tissue dimensional changes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Feb 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 25, 2025
CompletedFirst Posted
Study publicly available on registry
February 3, 2025
CompletedStudy Start
First participant enrolled
February 3, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
September 1, 2026
April 9, 2026
April 1, 2026
1.4 years
January 25, 2025
April 5, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Postoperative pain
Minimum and maximum values \[0-100\] Higher scores mean worse outcome (more pain) A questionnaire will be prepared and handed to patients on the day of the surgery. Patients will be instructed to answer the questions at the same time of the day and refer only to the palatal wound. Postoperative pain will be assessed using a Visual Analog Score (VAS) at 1 day, 3 days, 1 week, 2 weeks, 3 weeks, and 4 weeks postoperatively.
1 day, 3 days, 1 week, 2 weeks, 3 weeks, and 4 weeks
Secondary Outcomes (11)
Postoperative bleeding
1 day, 3 days, 1 week, 2 weeks, 3 weeks, and 4 weeks.
Discomfort at eating
1 day, 3 days, 1 week, 2 weeks, 3 weeks, and 4 weeks
Analgesic consumption
during the first week
Oral Health Impact Profile 5 questionnaire (OHIP5)
At 8 weeks
Epithelial gingival graft dimensions
Per-operatively
- +6 more secondary outcomes
Study Arms (2)
Suture
ACTIVE COMPARATORThis is the control group. In this group, 5-0 non-resorbable suspensory mattress sutures will be anchored to the soft tissues apical to the palatal wound area (5-0 Polypropylene, Prolene, Ethicon, Johnson and Johnson, New Brunswick, NJ, USA).
Cyanoacrylate bioadhesive
EXPERIMENTALThis is the test group. In this group, several drops of a high-viscosity cyanoacrylate bioadhesive will be applied (Cuantum Oral Adhesive, Cuantum Medical Cosmetics S.L., Spain) to create a uniform adhesive layer. No sutures will be placed.
Interventions
Hemostatic sutures at the palatal donor site; 5-0 non-resorbable suspensory mattress sutures will be anchored to the soft tissues apical to the palatal wound area (5-0 Polypropylene, Prolene, Ethicon, Johnson and Johnson, New Brunswick, NJ, USA).
Several drops of a high-viscosity cyanoacrylate bioadhesive will be applied (Cuantum Oral Adhesive, Cuantum Medical Cosmetics S.L., Spain) to create a uniform adhesive layer.
Eligibility Criteria
You may qualify if:
- Systemically healthy individuals older than 18 years old;
- Healthy periodontal status according to the AAP/EFP definition;
- Full-mouth plaque (FMPS) and bleeding scores (FMBS) ≤ 20%;
- No history of soft tissue harvesting.
You may not qualify if:
- Pregnancy or lactation;
- Self-reported smoking ≥10 cigarettes/day;
- Metabolic diseases that negatively affect soft tissue healing (i.e., diabetes mellitus);
- Any medication that may interfere with wound healing;
- Removable maxillary prostheses;
- Ongoing orthodontic therapy.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Clínica Universitària d'Odontologia - UIC Barcelona
Barcelona, Sant Cugat Del Valles, 08195, Spain
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
January 25, 2025
First Posted
February 3, 2025
Study Start
February 3, 2025
Primary Completion (Estimated)
July 1, 2026
Study Completion (Estimated)
September 1, 2026
Last Updated
April 9, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, CSR
- Time Frame
- After publishing
- Access Criteria
- Researchers must submit a formal data request outlining the purpose of their study, the specific data required, and the intended use.
The IPD to be shared will include: * Demographic data (e.g., age, gender, relevant medical history) * Clinical outcome measures, including postoperative morbidity, pain scores, and healing assessments * Three-dimensional soft tissue measurements, obtained from digital scans or clinical evaluations * Treatment allocation and intervention details, without identifiable information